Inglese

Concomitant Medications study Dyskinesia in Parkinson's disease NCT00363727

1 moduli  
General information
Descrizione

General information

Protocol indentifier
Descrizione

Protocol indentifier

Tipo di dati

text

Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
Visit date
Descrizione

Visit date

Tipo di dati

date

Visit Description
Descrizione

Visit Description

Tipo di dati

text

Concomitant medication
Descrizione

Concomitant medication

Concomitant medication
Descrizione

Record any changes to the subject's concomitant medications or any new medications taken since the last visit in the appropriate Concomitant Medications section.

Tipo di dati

text

L-Dopa medication changes
Descrizione

L-Dopa medication changes

Has there been any change in dose or frequency of L-Dopa medication since the last visit?
Descrizione

Note: Record any changes to the subject's L-Oopa medication taken since the last visit in the L-Dopa Medication section and contact GSK

Tipo di dati

boolean

Parkinson's Disease Symptom Control
Descrizione

Parkinson's Disease Symptom Control

Does the subject experience a reduction in Parkinson's Disease symptom control within 4 hours of the dose of L-dopa?
Descrizione

Parkinson's Disease Symptom Control

Tipo di dati

boolean

Ritorna all'inizio della pagina

Similar models

Concomitant Medications study Dyskinesia in Parkinson's disease NCT00363727

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
General information
Protocol indentifier
Item
Protocol indentifier
text
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit date
Item
Visit date
date
Visit Description
Item
Visit Description
text
Item Group
Concomitant medication
Concomitant medication
Item
Concomitant medication
text
Item Group
L-Dopa medication changes
change of L-Dopa medication
Item
Has there been any change in dose or frequency of L-Dopa medication since the last visit?
boolean
Item Group
Parkinson's Disease Symptom Control
Parkinson's Disease Symptom Control
Item
Does the subject experience a reduction in Parkinson's Disease symptom control within 4 hours of the dose of L-dopa?
boolean
Ritorna all'inizio della pagina